Prescription medicines treat conditions that require the expertise and supervision of qualified healthcare professionals. Decisions about the most appropriate course of treatment should always be based on the most objective information and not the most effective promotion. HAI Europe is committed to ensuring that information about prescription medicines comes from independent sources and not from commercial entities.
We monitor the regulations that prohibit advertising and that govern medicines information in order to prevent promotional messages about prescription medicines. We also work on medicines safety, and we believe that medicines that cause serious adverse drug reactions (ADRs) should be re-evaluated or removed from the market to protect patients.
Each patient is a unique medicines user with distinctive characteristics and lifestyle. As medicines are tested on a relatively small number of people before they are approved for use by the wider population, previously undetected reactions can emerge. HAI Europe promotes greater patient involvement in the reporting of ADRs so that harmful or ineffective medicines are identified more quickly, thereby reducing the threat to public health.
